55I LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.3M Buy
13,294
+8,501
+177% +$2.69M 0.12% 110
2022
Q2
$1.55M Buy
4,793
+2,794
+140% +$839K 0.04% 197
2022
Q1
$573K Buy
1,999
+247
+14% +$63.6K 0.01% 336
2021
Q4
$484K Sell
1,752
-2,455
-58% -$622K 0.01% 352
2021
Q3
$972K Buy
+4,207
New +$1.04M 0.03% 235
2020
Q4
Sell
-3,936
Closed -$583K 273
2020
Q3
$583K Buy
+3,936
New +$609K 0.05% 158

Other funds holding LLY

55I LLC's LLY Position: Q3 2022 in Review

55I LLC increased its Eli Lilly (LLY) stake by 177% in Q3 2022, buying an estimated $2.69M and bringing the position to 13,294 shares worth $4.3M. The position accounts for 0.12% of the portfolio, ranked #110.

55I LLC first reported a position in LLY in Q3 2020 and has held it in 6 quarters since. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • 55I LLC held 13,294 shares of Eli Lilly worth $4.3M as of Q3 2022.
  • 55I LLC bought 8,501 Eli Lilly shares in Q3 2022, an estimated $2.69M.
  • Eli Lilly made up 0.12% of 55I LLC's portfolio in Q3 2022, its #110 holding.
  • 55I LLC first reported a position in Eli Lilly in Q3 2020 and has held it in 6 quarters since.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.